Tactile Systems Technology Stock Climbs as 4Q Profit, Revenue Rise

Dow Jones

7 hours ago

By Kelly Cloonan

Shares of Tactile Systems Technology rose after the company logged higher profit and revenue in its latest quarter and said it expects its growth to continue this year.

The stock climbed 22% to $34.30 in after-hours trading on Tuesday. Through market close, shares are up 57% in the past year.

The medical technology company posted a profit of $10.6 million, or 46 cents a share, compared with $9.7 million, or 40 cents a share, a year earlier. Analysts polled by FactSet expected earnings of 44 cents a share.

Revenue rose 21% to $103.6 million, topping analyst estimates of $93.8 million.

The increase was driven by 16% growth in sales and rentals of its lymphedema product line and 66% growth in sales of its airway clearance product line.

The company expects continued momentum in its lymphedema business going forward, supporting revenue performance in line with overall market growth, Chief Executive Sheri Dodd said. "We believe we are entering 2026 from a position of operational and financial strength."

For the full year, the company guided for revenue of $357 million to $365 million, or up about 8% to 11%. Analysts were looking for $347.9 million.

Write to Kelly Cloonan at kelly.cloonan@wsj.com

(END) Dow Jones Newswires

February 17, 2026 18:24 ET (23:24 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2612499570"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2612499570\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2612499570?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-18 07:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2612499570","market":"nz","top_or_hot":-1,"title":"Tactile Systems Technology Stock Climbs as 4Q Profit, Revenue Rise","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Kelly Cloonan \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of Tactile Systems Technology rose after the company logged higher profit and revenue in its latest quarter and said it expects its growth to continue this year. \n</p>\n<p>\n  The stock climbed 22% to $34.30 in after-hours trading on Tuesday. Through market close, shares are up 57% in the past year. \n</p>\n<p>\n  The medical technology company posted a profit of $10.6 million, or 46 cents a share, compared with $9.7 million, or 40 cents a share, a year earlier. Analysts polled by FactSet expected earnings of 44 cents a share. \n</p>\n<p>\n  Revenue rose 21% to $103.6 million, topping analyst estimates of $93.8 million. \n</p>\n<p>\n  The increase was driven by 16% growth in sales and rentals of its lymphedema product line and 66% growth in sales of its airway clearance product line. \n</p>\n<p>\n  The company expects continued momentum in its lymphedema business going forward, supporting revenue performance in line with overall market growth, Chief Executive Sheri Dodd said. \"We believe we are entering 2026 from a position of operational and financial strength.\" \n</p>\n<p>\n  For the full year, the company guided for revenue of $357 million to $365 million, or up about 8% to 11%. Analysts were looking for $347.9 million. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Kelly Cloonan at kelly.cloonan@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 17, 2026 18:24 ET (23:24 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tactile Systems Technology Stock Climbs as 4Q Profit, Revenue Rise</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTactile Systems Technology Stock Climbs as 4Q Profit, Revenue Rise\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-02-18 07:24</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Kelly Cloonan \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of Tactile Systems Technology rose after the company logged higher profit and revenue in its latest quarter and said it expects its growth to continue this year. \n</p>\n<p>\n  The stock climbed 22% to $34.30 in after-hours trading on Tuesday. Through market close, shares are up 57% in the past year. \n</p>\n<p>\n  The medical technology company posted a profit of $10.6 million, or 46 cents a share, compared with $9.7 million, or 40 cents a share, a year earlier. Analysts polled by FactSet expected earnings of 44 cents a share. \n</p>\n<p>\n  Revenue rose 21% to $103.6 million, topping analyst estimates of $93.8 million. \n</p>\n<p>\n  The increase was driven by 16% growth in sales and rentals of its lymphedema product line and 66% growth in sales of its airway clearance product line. \n</p>\n<p>\n  The company expects continued momentum in its lymphedema business going forward, supporting revenue performance in line with overall market growth, Chief Executive Sheri Dodd said. \"We believe we are entering 2026 from a position of operational and financial strength.\" \n</p>\n<p>\n  For the full year, the company guided for revenue of $357 million to $365 million, or up about 8% to 11%. Analysts were looking for $347.9 million. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Kelly Cloonan at kelly.cloonan@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 17, 2026 18:24 ET (23:24 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TCMD","symbol_name":"Tactile Systems Technology Inc","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2612499570","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2612499570","pubTimestamp":1771370640,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Tactile Systems Technology rose after the company logged higher profit and revenue in its latest quarter and said it expects its growth to continue this year.The stock climbed 22% to $34.30 in after-hours trading on Tuesday. Through market close, shares are up 57% in the past year.The medical technology company posted a profit of $10.6 million, or 46 cents a share, compared with $9.7 million, or 40 cents a share, a year earlier. Analysts polled by FactSet expected earnings of 44 cents a share.Revenue rose 21% to $103.6 million, topping analyst estimates of $93.8 million.The increase was driven by 16% growth in sales and rentals of its lymphedema product line and 66% growth in sales of its airway clearance product line.The company expects continued momentum in its lymphedema business going forward, supporting revenue performance in line with overall market growth, Chief Executive Sheri Dodd said. \"We believe we are entering 2026 from a position of operational and financial str","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"TCMD":"Tactile Systems Technology Inc"},"translate_title":"随着第四季度利润和收入增长，触觉系统技术股价攀升","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TCMD":1.5},"content_text":"By Kelly Cloonan \n\n\n \n\n\n  Shares of Tactile Systems Technology rose after the company logged higher profit and revenue in its latest quarter and said it expects its growth to continue this year. \n\n\n  The stock climbed 22% to $34.30 in after-hours trading on Tuesday. Through market close, shares are up 57% in the past year. \n\n\n  The medical technology company posted a profit of $10.6 million, or 46 cents a share, compared with $9.7 million, or 40 cents a share, a year earlier. Analysts polled by FactSet expected earnings of 44 cents a share. \n\n\n  Revenue rose 21% to $103.6 million, topping analyst estimates of $93.8 million. \n\n\n  The increase was driven by 16% growth in sales and rentals of its lymphedema product line and 66% growth in sales of its airway clearance product line. \n\n\n  The company expects continued momentum in its lymphedema business going forward, supporting revenue performance in line with overall market growth, Chief Executive Sheri Dodd said. \"We believe we are entering 2026 from a position of operational and financial strength.\" \n\n\n  For the full year, the company guided for revenue of $357 million to $365 million, or up about 8% to 11%. Analysts were looking for $347.9 million. \n\n\n \n\n\n  Write to Kelly Cloonan at kelly.cloonan@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 17, 2026 18:24 ET (23:24 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}